Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'distal ulcerative colitis' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 127 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Naganuma, M; Iwao, T; Ogata, H; Inoue, N; Funakoshi, S; Yamamoto, S; Nakamura, Y; Ishii, F; Hibi, T
      Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: Comparison of orally administered mesalamine and sulfasalazine

      INFLAMMATORY BOWEL DISEASES
    2. Auwerda, JJA; Zijlstra, FJ; Tak, CJAM; van den Ingh, HFGM; Wilson, JHP; Ouwendijk, RJT
      Ridogrel enemas in distal ulcerative colitis

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    3. Kanauchi, O; Iwanaga, T; Andoh, A; Araki, Y; Nakamura, T; Mitsuyama, K; Suzuki, A; Hibi, T; Bamba, T
      Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    4. Luhrs, H; Gerke, T; Schauber, J; Dusel, G; Melcher, R; Scheppach, W; Menzel, T
      Cytokine-activated degradation of inhibitory kappa B protein alpha is inhibited by the short-chain fatty acid butyrate

      INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
    5. Luhrs, H; Gerke, T; Boxberger, F; Backhaus, K; Melcher, R; Scheppach, W; Menzel, T
      Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activationin human epithelial cells

      DIGESTIVE DISEASES AND SCIENCES
    6. Liu, Q; Shimoyama, T; Suzuki, K; Umeda, T; Nakaji, S; Sugawara, K
      Effect of sodium butyrate on reactive oxygen species generation by human neutrophils

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    7. Nos, P; Hinojosa, J; Gomollon, F; Ponce, J
      Budesonide in inflammatory bowel disease: a meta-analysis

      MEDICINA CLINICA
    8. Scholmerich, J; Stange, EF
      Chronic inflammatory bowel disease - Standards and outlook in pharmacotherapy

      INTERNIST
    9. Henningsson, AM; Nyman, EMGL; Bjorck, IME
      Content of short-chain fatty acids in the hindgut of rats fed processed bean (Phaseolus vulgaris) flours varying in distribution and content of indigestible carbohydrates

      BRITISH JOURNAL OF NUTRITION
    10. Scholmerich, J
      Is there any step-wise treatment of chronic inflammatory intestinal disease?

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    11. Okamoto, T; Sasaki, M; Tsujikawa, T; Fujiyama, Y; Bamba, T; Kusunoki, M
      Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats

      JOURNAL OF GASTROENTEROLOGY
    12. De Vos, M
      Clinical pharmacokinetics of slow release mesalazine

      CLINICAL PHARMACOKINETICS
    13. Pender, SLF; Quinn, JJ; Sanderson, IR; MacDonald, TT
      Butyrate upregulates stromelysin-1 production by intestinal mesenchymal cells

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    14. Manokas, T; Fromkes, JJ; Sundaram, U
      Effect of chronic inflammation on ileal short-chain fatty acid/bicarbonateexchange

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    15. Schauber, J; Bark, T; Jaramillo, E; Katouli, M; Sandstedt, B; Svenberg, T
      Local short-chain fatty acids supplementation without beneficial effect oninflammation in excluded rectum

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    16. Venkatraman, A; Ramakrishna, BS; Pulimood, AB; Patra, S; Murthy, S
      Increased permeability in dextran sulphate colitis in rats: Time course ofdevelopment and effect of butyrate

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    17. Klotz, U
      The role of aminosalicylates at the beginning of the new millennium in thetreatment of chronic inflammatory bowel disease

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    18. Gomollon, F
      Clinical experience with budesonide in Spain

      DRUGS OF TODAY
    19. Stotland, BR; Stein, RB; Lichtenstein, GR
      Advances in inflammatory bowel disease

      MEDICAL CLINICS OF NORTH AMERICA
    20. Thiesen, A; Wild, G; Keelan, M; Clandinin, MT; McBurney, M; Van Aerde, J; Thomson, ABR
      Ontogeny of intestinal nutrient transport

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    21. Marteau, P; Florent, C
      Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    22. Stein, RB; Hanauer, SB
      Medical therapy for inflammatory bowel disease

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    23. Sands, BE
      Novel therapies for inflammatory bowel disease

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    24. Michetti, P; Peppercorn, MA
      Medical therapy of specific clinical presentations

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    25. Han, PD; Burke, A; Baldassano, RN; Rombeau, JL; Lichtenstein, GR
      Nutrition and inflammatory bowel disease

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    26. Wu, GD; Huang, N; Wen, XM; Keilbaugh, SA; Yang, HY
      High-level expression of I kappa B-beta in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role

      JOURNAL OF LEUKOCYTE BIOLOGY
    27. Klotz, U
      Pharmacokinetic properties of various preparations of 5-aminosalicylic acid (5-ASA) and budesonide

      MEDIZINISCHE KLINIK
    28. Papillon, E; Bonaz, B; Fournet, J
      Short chain fatty acids (SCFA): effects on gastrointestinal function and therapeutic potential in Gastroenterology

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    29. Carbonnel, F; Cosnes, J
      Nutritional support in inflammatory bowel disease: present and future

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    30. Jergens, AE
      Inflammatory bowel disease - Current perspectives

      VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE
    31. Kien, CL; Murray, RD; Qualman, SJ; Marcon, M
      Lactulose feeding in piglets - A model for persistent diarrhea and colitisinduced by severe sugar malabsorption

      DIGESTIVE DISEASES AND SCIENCES
    32. Andoh, A; Bamba, T; Sasaki, M
      Physiological and anti-inflammatory roles of dietary fiber and butyrate inintestinal functions

      JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
    33. Fukushima, K; Sasaki, I; Takahashi, K; Naito, H; Matsuno, S
      Lipopolysaccharide- and proinflammatory cytokine-induced energy productionin intestinal and colonic epithelial cell lines

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    34. Geerling, BJ; Stockbrugger, RW; Brummer, RJM
      Nutrition and inflammatory bowel disease: An update

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    35. Martinsson, T; Ljung, T; Rubio, C; Hellstrom, PM
      Beneficial effects of ropivacaine in rat experimental colitis

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    36. Rabbani, GH; Albert, MJ; Rahman, ASMH; Isalm, MM; Islam, KMN; Alam, K
      Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis

      JOURNAL OF INFECTIOUS DISEASES
    37. Prantera, C; Cottone, M; Pallone, F; Annese, V; Franze, A; Cerutti, R; Porro, GB
      Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial

      GASTROENTEROLOGY
    38. Kaya, E; Gur, ES; Ozguc, H; Bayer, A; Tokyay, R
      L-glutamine enemas attenuate mucosal injury in experimental colitis

      DISEASES OF THE COLON & RECTUM
    39. Kitamura, K; Andoh, A; Inoue, T; Amakata, Y; Hodohara, K; Fujiyama, Y; Bamba, T
      Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    40. Andoh, A; Fujiyama, Y; Hata, K; Araki, Y; Takaya, H; Shimada, M; Bamba, T
      Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    41. Robinson, M
      Medical therapy of inflammatory bowel disease for the 21st century

      EUROPEAN JOURNAL OF SURGERY
    42. SMITH JG; YOKOYAMA WH; GERMAN JB
      BUTYRIC-ACID FROM THE DIET - ACTIONS AT THE LEVEL OF GENE-EXPRESSION

      Critical reviews in food science and nutrition
    43. DIELEMAN LA; HEIZER WD
      NUTRITIONAL ISSUES IN INFLAMMATORY BOWEL-DISEASE

      Gastroenterology clinics of North America
    44. FRIEND DR
      REVIEW ARTICLE - ISSUES IN ORAL-ADMINISTRATION OF LOCALLY ACTING GLUCOCORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY BOWEL-DISEASE

      Alimentary pharmacology & therapeutics
    45. COOK SI; SELLIN JH
      REVIEW ARTICLE - SHORT-CHAIN FATTY-ACIDS IN HEALTH AND DISEASE

      Alimentary pharmacology & therapeutics
    46. BICKSTON SJ; COMINELLI F
      RECENT DEVELOPMENTS IN THE MEDICAL THERAPY OF INFLAMMATORY BOWEL-DISEASE

      Current opinion in gastroenterology
    47. PALMEN MJHJ; DIELEMAN LA; SOESATYO M; PENA AS; MEUWISSEN SGM; VANREES EP
      EFFECTS OF LOCAL BUDESONIDE TREATMENT ON THE CELL-MEDIATED IMMUNE-RESPONSE IN ACUTE AND RELAPSING COLITIS IN RATS

      Digestive diseases and sciences
    48. Hassani, Z; Cuillerier, E; Cellier, C; Marteau, P
      Therapeutic use of short-chain fatty acids in colorectal disease.

      ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE
    49. ROGLER G; ANDUS T; SCHOLMERICH J
      STANDARDS, PERSPECTIVES AND LIMITS OF THE CONSERVATIVE THERAPY OF INFLAMMATORY BOWEL-DISEASE

      Zentralblatt fur Chirurgie
    50. SABATE JM; CHAUSSADE S
      MODALITIES OF CORTICOSTEROID-THERAPY IN INFLAMMATORY BOWEL-DISEASE

      La Semaine des hopitaux de Paris
    51. STOTLAND BR; LICHTENSTEIN GR
      NEWER TREATMENTS FOR INFLAMMATORY BOWEL-DISEASE

      Medicamentos de actualidad
    52. POUILLART PR
      ROLE OF BUTYRIC-ACID AND ITS DERIVATIVES IN THE TREATMENT OF COLORECTAL-CANCER AND HEMOGLOBINOPATHIES

      Life sciences (1973)
    53. FLEIG WE
      CONSERVATIVE TREATMENT STRATEGIES IN CHRONIC INFLAMMATORY BOWEL-DISEASE

      Der Internist
    54. GROSS V
      EFFICACY OF DIFFERENT MESALAMINE-RELEASING DRUGS

      Gastroenterology (New York, N.Y. 1943)
    55. SUAREZ FL; FURNE JK; SPRINGFIELD J; LEVITT MD
      BISMUTH SUBSALICYLATE MARKEDLY DECREASES HYDROGEN-SULFIDE RELEASE IN THE HUMAN COLON

      Gastroenterology
    56. RUTGEERTS P
      MEDICAL THERAPY OF INFLAMMATORY BOWEL-DISEASE

      Digestion
    57. BICKSTON SJ; COMINELLI F
      INFLAMMATORY BOWEL-DISEASE - SHORT-TERM AND LONG-TERM TREATMENTS

      Disease-a-month
    58. GUSLANDI M
      UNCONVENTIONAL TREATMENTS FOR INFLAMMATORY BOWEL-DISEASE

      Current therapeutic research
    59. HUANG N; KATZ JP; MARTIN DR; WU GD
      INHIBITION OF IL-8 GENE-EXPRESSION IN CACO-2 CELLS BY COMPOUNDS WHICHINDUCE HISTONE HYPERACETYLATION

      Cytokine
    60. SCHEPPACH W; MULLER JG; BOXBERGER F; DUSEL G; RICHTER F; BARTRAM HP; CHRISTL SU; DEMPFLE CE; KASPER H
      HISTOLOGICAL-CHANGES IN THE COLONIC MUCOSA FOLLOWING IRRIGATION WITH SHORT-CHAIN FATTY-ACIDS

      European journal of gastroenterology & hepatology
    61. RICHTER F; SCHEPPACH W
      INNOVATIONS IN TOPICAL THERAPY

      Bailliere's clinical gastroenterology
    62. TESHIMA T; HANKS GE; HANLON AL; PETER RS; SCHULTHEISS TE
      RECTAL BLEEDING AFTER CONFORMAL 3D TREATMENT OF PROSTATE-CANCER - TIME TO OCCURRENCE, RESPONSE TO TREATMENT AND DURATION OF MORBIDITY

      International journal of radiation oncology, biology, physics
    63. CAMPBELL JM; FAHEY GC
      PSYLLIUM AND METHYLCELLULOSE FERMENTATION PROPERTIES IN RELATION TO INSOLUBLE AND SOLUBLE FIBER STANDARDS

      Nutrition research
    64. MOODY GA; EADEN JA; HELYES Z; MAYBERRY JF
      ORAL OR RECTAL ADMINISTRATION OF DRUGS IN IBD

      Alimentary pharmacology & therapeutics
    65. LUCIDARME D; MARTEAU P; FOUCAULT M; VAUTRIN B; FILOCHE B
      EFFICACY AND TOLERANCE OF MESALAZINE SUPPOSITORIES VS HYDROCORTISONE FOAM IN PROCTITIS

      Alimentary pharmacology & therapeutics
    66. HAMEDANI R; FELDMAN RD; FEAGAN BG
      DRUG DEVELOPMENT IN INFLAMMATORY BOWEL-DISEASE - BUDESONIDE - A MODELOF TARGETED THERAPY

      Alimentary pharmacology & therapeutics
    67. STEINHART AH; GREENBERG GR
      NUTRITION IN INFLAMMATORY BOWEL-DISEASE

      Current opinion in gastroenterology
    68. RAMOS MG; BAMBIRRA EA; CARA DC; VIEIRA EC; ALVAREZLEITE JI
      ORAL-ADMINISTRATION OF SHORT-CHAIN FATTY-ACIDS REDUCES THE INTESTINALMUCOSITIS CAUSED BY TREATMENT WITH ARA-C IN MICE FED COMMERCIAL OR ELEMENTAL DIETS

      Nutrition and cancer
    69. BORUM ML; GINSBERG A
      HYPERSENSITIVITY TO 5-ASA SUPPOSITORIES

      Digestive diseases and sciences
    70. BJORCK S; JENNISCHE E; DAHLSTROM A; AHLMAN H
      INFLUENCE OF TOPICAL RECTAL APPLICATION OF DRUGS ON DEXTRAN SULFATE-INDUCED COLITIS IN RATS

      Digestive diseases and sciences
    71. SCHEPPACH W; CHRISTL SU; BARTRAM HP; RICHTER F; KASPER H
      EFFECTS OF SHORT-CHAIN FATTY-ACIDS ON THE INFLAMED COLONIC MUCOSA

      Scandinavian journal of gastroenterology
    72. BRYNSKOV J
      THERAPEUTIC OPTIONS FOR PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - NEW STEROIDS

      Medicamentos de actualidad
    73. MARTINSSON T; ODA T; FERNVIK E; ROEMPKE K; DALSGAARD CJ; SVENSJO E
      ROPIVACAINE INHIBITS LEUKOCYTE ROLLING, ADHESION AND CD11B CD18 EXPRESSION/

      The Journal of pharmacology and experimental therapeutics
    74. FLEIG WE
      TOPICAL STEROIDS IN CHRONIC INFLAMMATORY BOWEL-DISEASE

      Der Internist
    75. CHERBONNELLASSERRE CL; LINARESCRUZ G; RIGAUT JP; SABATIER L; DUTRILLAUX B
      STRONG DECREASE IN BIOTIN CONTENT MAY CORRELATE WITH METABOLIC ALTERATIONS IN COLORECTAL ADENOCARCINOMA

      International journal of cancer
    76. CAMPIERI M; FERGUSON A; DOE W; PERSSON T; NILSSON LG; MALCHOW H; PRANTERA C; MANI V; OMORAIN C; SELBY W; PALLONE F; DIPIETRALATA MM; SJODAHL R; FLORIN T; SMITH P; BIANCHI P; LOFBERG R; RUTGEERTS P; SMALLWOOD R; LAMERS HW; TASMANJONES C; HUNTER JO; HODGSON H; DANIELSSON A; LEE FI; PIACITELLI G; GIOVANNI S; ELLIS A; WEIR DG
      ORAL BUDESONIDE IS AS EFFECTIVE AS ORAL PREDNISOLONE IN ACTIVE CROHNS-DISEASE

      Gut
    77. BREUER RI; SOERGEL KH; LASHNER BA; CHRIST ML; HANAUER SB; VANAGUNAS A; HARIG JM; KESHAVARZIAN A; ROBINSON M; SELLIN JH; WEINBERG D; VIDICAN DE; FLEMAL KL; RADEMAKER AW
      SHORT-CHAIN FATTY-ACID RECTAL IRRIGATION FOR LEFT-SIDED ULCERATIVE-COLITIS - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

      Gut
    78. WILSON AJ; GIBSON PR
      SHORT-CHAIN FATTY-ACIDS PROMOTE THE MIGRATION OF COLONIC EPITHELIAL-CELLS IN-VITRO

      Gastroenterology
    79. MINER PB
      FACTORS INFLUENCING THE RELAPSE OF PATIENTS WITH INFLAMMATORY BOWEL-DISEASE

      The American journal of gastroenterology
    80. ROBINSON M
      OPTIMIZING THERAPY FOR INFLAMMATORY BOWEL-DISEASE

      The American journal of gastroenterology
    81. SHAH SA; PEPPERCORN MA
      A COMPARATIVE REVIEW OF TOPICAL THERAPIES FOR INFLAMMATORY BOWEL-DISEASE

      CLINICAL IMMUNOTHERAPEUTICS
    82. WINTER H; GRAND R
      MEDICAL THERAPY FOR CHILDREN WITH INFLAMMATORY BOWEL-DISEASE

      Inflammatory bowel diseases
    83. GROSS V; ANDUS T; CAESAR I; BISCHOFF SC; LOCHS H; TROMM A; SCHULZ HJ; BAR U; WEBER A; GIEREND M; EWE K; SCHOLMERICH J; ADAM B; BAUERLE H; GOEBELL H; HOFFMANN R; JAKOB G; JUNGE U; LORENZMEYER H; MANNS MP; MAY B; MALCHOW H; RIEMANN JF; SCHMIDT C; SEIFERT E; TILLINGER W; VOGELSANG H; WORDEHOFF D
      ORAL PH-MODIFIED RELEASE BUDESONIDE VERSUS 6-METHYLPREDNISOLONE IN ACTIVE CROHNS-DISEASE

      European journal of gastroenterology & hepatology
    84. ARDIZZONE S; PORRO GB
      THE TOPICAL TREATMENT OF DISTAL ULCERATIVE-COLITIS

      European journal of gastroenterology & hepatology
    85. LUCIANO L; HASS R; BUSCHE R; VONENGELHARDT W; REALE E
      WITHDRAWAL OF BUTYRATE FROM THE COLONIC MUCOSA TRIGGERS MASS APOPTOSIS PRIMARILY IN THE G(0) G(1), PHASE OF THE CELL-CYCLE/

      Cell and tissue research
    86. THIESEN A; THOMSON ABR
      REVIEW ARTICLE - OLDER SYSTEMIC AND NEWER TOPICAL GLUCOCORTICOSTEROIDS AND THE GASTROINTESTINAL-TRACT

      Alimentary pharmacology & therapeutics
    87. STONEROOK MJ; TEFEND KS; SHARMA HM; PECK OC; WOOD JD
      FECAL SHORT-CHAIN FATTY-ACIDS ASSOCIATED WITH INFLAMMATION IN COTTON-TOP TAMARIN MODEL FOR IDIOPATHIC COLITIS

      Digestive diseases and sciences
    88. STOTLAND BR; LICHTENSTEIN GR
      NEWER TREATMENTS FOR INFLAMMATORY BOWEL-DISEASE

      Primary care
    89. BONNER GF
      CURRENT MEDICAL THERAPY FOR INFLAMMATORY BOWEL-DISEASE

      Southern medical journal
    90. MEIER R
      CHRONIC INFLAMMATORY BOWEL-DISEASE AND NU TRITION

      Schweizerische medizinische Wochenschrift
    91. DAHLSTROM K; EDSBACKER S; KALLEN A
      RECTAL PHARMACOKINETICS OF BUDESONIDE

      European Journal of Clinical Pharmacology
    92. HANAUER SB
      DRUG-THERAPY - INFLAMMATORY BOWEL-DISEASE

      The New England journal of medicine
    93. KORBER J; KARAUS M; HAMPEL KE
      DRUG-THERAPY OF CHRONIC INFLAMMATORY BOWE L-DISEASE

      Die medizinische Welt
    94. BUTZNER JD; PARMAR R; BELL CJ; DALAL V
      BUTYRATE ENEMA THERAPY STIMULATES MUCOSAL REPAIR IN EXPERIMENTAL COLITIS IN THE RAT

      Gut
    95. LEE FI; JEWELL DP; MANI V; KEIGHLEY MRB; KINGSTON RD; RECORD CO; GRACE RH; DANIELS S; PATTERSON J; SMITH K
      A RANDOMIZED TRIAL COMPARING MESALAZINE AND PREDNISOLONE FOAM ENEMAS IN PATIENTS WITH ACUTE DISTAL ULCERATIVE-COLITIS

      Gut
    96. ALSABBAGH R; SINICROPE FA; SELLIN JH; SHEN Y; ROUBEIN L
      EVALUATION OF SHORT-CHAIN FATTY-ACID ENEMAS - TREATMENT OF RADIATION PROCTITIS

      The American journal of gastroenterology
    97. JOHNSON IT
      BUTYRATE AND MARKERS OF NEOPLASTIC CHANGE IN THE COLON

      European journal of cancer prevention
    98. HANAUER SB; SCHULMAN MI
      NEW THERAPEUTIC APPROACHES

      Gastroenterology clinics of North America
    99. BITTON A; PEPPERCORN MA
      MEDICAL-MANAGEMENT OF SPECIFIC CLINICAL PRESENTATIONS

      Gastroenterology clinics of North America
    100. GIBSON P; FOLINO M; MCINTYRE A; ROSELLA O; FINCH C; YOUNG G
      DIETARY MODULATION OF COLONIC MUCOSAL UROKINASE ACTIVITY IN RATS

      Journal of gastroenterology and hepatology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 17:51:29